(Q39201935)
Statements
Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production (English)
Isabel Poschke
Giusy Gentilcore
Maria Nyström
Johan Hansson